Get the app
Healthcare3 min reading time

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Covered by 2 sources
Read the full article
Miles Wang, an OpenAI researcher known for AI-driven scientific discovery, is leaving to start a drug discovery AI startup. The company is reportedly in talks to raise $200M at a $2B valuation, with Lightspeed as a potential lead investor. The startup aims to repurpose existing drugs using AI, accelerating drug development timelines.

Covered by 2 sources

#ai-drug-discovery#drug-repurposing#lightspeed#miles-wang#openai

More in Healthcare

Healthcare32 min read

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Nature
Healthcare3 min read

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

Futurism
Healthcare2 min read

UK government sets out $800 million for AI security funding

ET AI (The Economic Times)